'The biggest challenge is to bring researchers together to be synergistic and bring diabetes research forward. Research needs to be diverse and inclusive.' @professorcm EASD INNODIA JDRF Research Innovative Health Initiative

Prediabetes is a risk factor for type 2 #diabetes, diabetes complications and mortality – what is the best approach for reducing the potential health burden that it poses to both the individual and society at large? #T2D Read more: easd-elearning.org/addressing-the…

Participan 💬 Psicodiabetes, dulcenana_aguayo, F. Javier Ortega ❤️‍🩹, ADT, Vivetudiabetes y PatriciaBritoRodriguez. ¡No te lo pierdas! #Implica2DM2 Abbott  fedesp.es/agenda/tuitead…

Barriers to urine ACR screening in primary care Being discussed at PCDiabetesEurope meeting in Barcelona Prof. F Xavier cos, MD, PhD

Packed room PCDiabetesEurope Conference in Barcelona Prof David Matthews receiving the Paul Cromme Award Really well deserved 👏👏👏

Type 2 Diabetes as an infectious epidemic disease (by David Matthews-UK) in PCDE Congress. Similarities and Differences with COVID ‘19 pandemic

Keynote lecture PCDiabetesEurope Michael Nauck "Dual agonists, new horizons in incretin therapies"

Fully agree !!! Warming this team building for future challenges but mainly to keep our friendship more committed if that is still needed. PCDiabetesEurope

La Jornada Anual 2⃣0⃣2⃣2⃣de l'ICS Catalunya Central ha servit per compartir experiències d’èxit dels equips d’Atenció Primària de la Catalunya Central i fer un balanç anual de la feina feta, així com posar en relleu els reptes de futur del sistema sanitari. 🔗bit.ly/3JitEx7

Nuestro compañero @manelmatacases detalla el valor y la utilidad de los registros de datos de #diabetESP, que tan bien conoce. Sólo analizando esta información, es posible conocer, evidenciar y aprender para implementar intervenciones de calidad. #pcde2023 redGDPS Diabetes PCDiabetesEurope

ICSCC: un referent que integra assistència, docència i recerca. Gràcies per la tasca que feu!!!

Brilliant Prof D Matthews lecture at the Paul Cromme award lecture 2023 at #pcde2023 PCDiabetesEurope redGDPS Diabetes SED Diabetes WONCA Europe WONCA

Without any doubt #diabetes #prevention must be a priority everywhere with special attention in High risk individuals . DPS study and #deplancat study ( ncbi.nlm.nih.gov/pmc/articles/P… demostrate evidence of diabetes prevention in real life Time to REACT!!! PCDiabetesEurope IDIAPJGol @EASD

A clear recognizition from the Primary care community for his contribution in the #diabetes field. His lecture has been extraordinary!!! PCDiabetesEurope WONCA Europe @pcdsociety

Lideratge consolidat en #innovación en atenció Primària. ICS Catalunya Central com a motor de transformació del sistema de Salut a Catalunya. Josep Vidal-Alaball MD, PhD, MPH IDIAPJGol Salut ICS. Generalitat @ticsalut

Jornada de referencia per copsar els reptes actuals i les propostes de transformació del sistema de Salut. ICS Catalunya Central com a motor del canvi. ICS. Generalitat Salut IDIAPJGol Xavier Perez Berruezo

Deserved award to a great researcher!!! PCDiabetesEurope committed to support young researchers and fund and publish research in the field. WONCA Europe redGDPS Diabetes @pcdsociety PCDiabetesEurope EASD x.com/kamleshkhunti/…

Priority aspects to tackle to address inequalities in #diabetes #minorities . Prof Kamlesh Khunti PCDiabetesEurope 🌱Leicester Diabetes @pcdsociety WONCA Europe redGDPS Diabetes EASD

Now published Retatrutide, a GIP, GLP-1 and glucagon receptor agonist Phase 2 RCT vs Dulaglutide 1.5mg & placebo 2% ⬇️ HbA1c 17% ⬇️ weight sciencedirect.com/science/articl…

Results for our INTEGRA study (Spain) out Multifaceted intervention to ⬇️ therapeutic inertia in primary care associated with improvements in glycaemic control With our Spanish friends Led by Dídac Mauricio et al With Prof. F Xavier cos, MD, PhD @manelmatacases …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…